policy
GLP-1 Use Is Rising Fast Among Young Americans
A U.S. analysis finds steep growth in prescriptions among adolescents and young adults, sometimes alongside bariatric surgery.
Summary
A U.S. analysis finds steep growth in prescriptions among adolescents and young adults, sometimes alongside bariatric surgery.
UT Southwestern researchers report rapidly increasing use of GLP-1 weight-loss medicines among U.S. adolescents and young adults, including patients also receiving metabolic and bariatric surgery. The JAMA Pediatrics study tracks utilization patterns rather than proving long-term benefits or harms for every age group. The authors frame the change as a reason to study safety, access, treatment sequencing, and follow-up as medical obesity care expands among younger patients.
Why it matters
A U.S. analysis finds steep growth in prescriptions among adolescents and young adults, sometimes alongside bariatric surgery.
Limits and context
No additional limitation was separately recorded.
Key claims
A U.S. analysis finds steep growth in prescriptions among adolescents and young adults, sometimes alongside bariatric surgery.
Evidence: source-2026-07-21-010
Sources
- UT Southwestern via Newswise: Youth GLP-1 useUT Southwestern via Newswise · secondary reporting
Corrections
No corrections have been recorded for this story.